Stephanie Wolfe
Neurology · Greensboro, NCNPI 1043505415
Payments from drug & device makers
Across 199 payments — averaging $27.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$1K
- UCB, Inc.$1K
- Jazz Pharmaceuticals Inc.$464
- Neurelis, Inc.$431
- Aucta Pharmaceuticals, Inc.$283
- Aquestive Therapeutics, Inc.$174
- plus $1K from 25 others
What the payments were for
- Travel & lodging$96717%
- Food & beverage$4,56383%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 6 | $1,380 |
| UCB, Inc. | 59 | $1,325 |
| Jazz Pharmaceuticals Inc. | 18 | $464 |
| Neurelis, Inc. | 24 | $431 |
| Aucta Pharmaceuticals, Inc. | 16 | $283 |
| Aquestive Therapeutics, Inc. | 9 | $174 |
| Supernus Pharmaceuticals, Inc. | 9 | $153 |
| Greenwich Biosciences, Inc. | 6 | $123 |
| Acadia Pharmaceuticals Inc | 5 | $122 |
| Gilead | 1 | $117 |
| Medtronic | 2 | $108 |
| Tris Pharma Inc | 5 | $107 |
| Corium, LLC | 5 | $93 |
| SK Life Science, Inc. | 3 | $90 |
| Philips North America LLC | 4 | $57 |
| Eisai Inc. | 3 | $55 |
| Amneal Pharmaceuticals LLC | 3 | $52 |
| Zogenix Inc. | 3 | $47 |
| Biomarin Pharmaceutical Inc. | 2 | $42 |
| Biogen | 3 | $40 |
| Aprecia Pharmaceuticals, LLC | 2 | $34 |
| Azurity Pharmaceuticals, Inc. | 2 | $30 |
| Orchard Therapeutics North America | 1 | $28 |
| Baxter Healthcare | 1 | $28 |
| Merck | 1 | $25 |
| Amgen | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Tersera Therapeutics LLC | 1 | $21 |
| Sarepta Therapeutics, Inc. | 1 | $21 |
| PTC Therapeutics, Inc. | 1 | $21 |
| Metacel Pharmaceuticals LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$1,355
- Fintepla$102
How this compares
$5,530 in reported general payments places this provider in the 65th percentile of 566 neurology providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Felbamate | 12 | $3,154 |
| Gabapentin | 19 | $664 |
| Oxcarbazepine | 14 | $587 |
| Levetiracetam | 11 | $265 |
Paid to pharmacies, not to this prescriber.
Other neurology in Greensboro
- Pramod SethiGreensboro$2.9M
- Marshall FreemanGreensboro$1.9M
- Richard SaterGreensboro$1.9M
- Mohammad BolouriCharlotte$16.6M
- Katherine PetersDurham$11M
- John ScagnelliRaleigh$9.3M
- T RaoCharlotte$4M
- Robert ArmstrongAsheville$2.7M
- Casey JeffreysRaleigh$2.2M
- Mitchell IsaacWinston Salem$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.